fda warning glp-1 compounding september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our NCL Issues a Second Alert

Diabetes Res Clin Pract 2015;110:2637

This muscle atrophy can lead to a flat or sagging appearance

I would also argue that estrogen hormone therapy, progesterone, testosterone, when indicated, is going to have a synergistic effect with these GLP ones

Melatonin's Potential observed outcomes in study models: It May Be in Your Genes [PMID: 35787871] Laboratory literature summary: Melatonin's Potential observed outcomes in study models: It May Be in Your Genes

When compared to the placebo group, PBMCs isolated from individuals with T2DM who received L-GSH supplementation for 3-months had a significantly reduced burden of BCG ( Figure 6A )